ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years
Charles J. David
Matched on ORCID iD 0000-0002-1257-8198; OpenAlex author ID A5070381062. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 20
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 6
- Epithelial FOXP3: The Silent Spark That Lights the Fire of Pancreatic Cancer. Co-author DOI 10.1016/j.canlet.2026.218738↗
- A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.ccell.2026.03.021↗
- Targeting TUT1 Depletes Tri-snRNP Pools to Suppress Splicing and Inhibit Pancreatic Cancer Cell Survival. Co-author DOI 10.1158/0008-5472.can-24-2563↗
- Protocol to package and concentrate adeno-associated virus serotype 8 for use in autochthonous mouse models of pancreatic cancer. Last author DOI 10.1016/j.xpro.2023.102108↗
- Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer. Last author DOI 10.1038/s43018-020-00134-z↗
- ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-19-0529↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Meilian Zhuo · 3 shared papers, 2021–2026 · strength 0.61
- Paper Protocol to package and concentrate adeno-associated virus serotype 8 for use in autochthonous mouse models of pancreat… DOI 10.1016/j.xpro.2023.102108↗
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
- Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗
- Mo Chen · 3 shared papers, 2021–2026 · strength 0.61
- Paper Targeting TUT1 Depletes Tri-snRNP Pools to Suppress Splicing and Inhibit Pancreatic Cancer Cell Survival. DOI 10.1158/0008-5472.can-24-2563↗
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
- Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗
- Ziwei Guo · 1 shared paper, 2025 · strength 0.30
- Junya Peng · 2 shared papers, 2021–2026 · strength 0.30
- Yupei Zhao · 2 shared papers, 2021–2026 · strength 0.30
- Xianlin Han · 1 shared paper, 2026 · strength 0.21
- Ruizhe He · 1 shared paper, 2026 · strength 0.21
- Mingyang Liu · 1 shared paper, 2026 · strength 0.21
- Menghua Dai · 1 shared paper, 2026 · strength 0.21
- Weibin Wang · 1 shared paper, 2026 · strength 0.21
- Yun-Han Huang · 1 shared paper, 2020 · strength 0.10
- Peter J. Allen · 1 shared paper, 2020 · strength 0.10
- Steven D Leach · 1 shared paper, 2020 · strength 0.10
- Christine A. Iacobuzio–Donahue · 1 shared paper, 2020 · strength 0.10
- Joan Massague · 1 shared paper, 2020 · strength 0.10
- Yong Li · 1 shared paper, 2021 · strength 0.10
- Xun Lan · 1 shared paper, 2021 · strength 0.10
- Wenze Wang · 1 shared paper, 2021 · strength 0.10
- Wenming Wu · 1 shared paper, 2021 · strength 0.10
- Jing Xue · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.